Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every quarter.
Link as first comment.
#longevity #geroscience #DeepLongevity #Accrua #aging
Link as first comment.
#longevity #geroscience #DeepLongevity #Accrua #aging
October 12, 2026 at 9:22 AM
Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every quarter.
Link as first comment.
#longevity #geroscience #DeepLongevity #Accrua #aging
Link as first comment.
#longevity #geroscience #DeepLongevity #Accrua #aging
Accrua by Deep Longevity uses an AI model to identify 'fast agers' via blood tests and directs them to GLP-1 treatments. The US telehealth platform is scheduled to launch in October 2026.
#BiologicalAGE #GLP1 #DeepLongevity
#BiologicalAGE #GLP1 #DeepLongevity
Accrua platform launches in the US in October 2026
Source: Longevity.Technology
realfeedapp.com
October 10, 2026 at 6:00 AM
Accrua by Deep Longevity uses an AI model to identify 'fast agers' via blood tests and directs them to GLP-1 treatments. The US telehealth platform is scheduled to launch in October 2026.
#BiologicalAGE #GLP1 #DeepLongevity
#BiologicalAGE #GLP1 #DeepLongevity